Clinical Trial Update: Integrating ePReBMs From Phoenix in Respiratory Diseases [NA]

View source ↗

Summary

A clinical trial evaluating ePReBMs from Phoenix in respiratory diseases has been terminated, with conditions including pulmonary hypertension, chronic obstruct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Interstitial Lung Disease
• Pulmonary Hypertension

Snippet

Sponsor: University of Alberta | Conditions: Pulmonary Hypertension, COPD | NA | Status: TERMINATED